Milestone Pharmaceuticals IncNASDAQ:MIST
- LAST PRICE1.7100
- TODAY'S CHANGE (%)-0.1000 (-5.5249%)
- Bid / Lots1.7100/ 12
- Ask / Lots1.9400/ 1
- Open / Previous Close1.8100 / 1.8100
- Day Range
- 52 Week Range
- Volume436,076
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MIST |
|---|---|---|
| 09:32 ET | 6352 | 1.78 |
| 09:42 ET | 200 | 1.795 |
| 09:44 ET | 250 | 1.78 |
| 09:55 ET | 1000 | 1.7978 |
| 10:00 ET | 1145 | 1.79 |
| 10:02 ET | 4299 | 1.77 |
| 10:04 ET | 3700 | 1.765 |
| 10:06 ET | 1000 | 1.7698 |
| 10:08 ET | 2100 | 1.7617 |
| 10:09 ET | 1300 | 1.7693 |
| 10:11 ET | 2600 | 1.75 |
| 10:13 ET | 18840 | 1.75 |
| 10:15 ET | 6000 | 1.7592 |
| 10:18 ET | 400 | 1.76 |
| 10:20 ET | 200 | 1.755 |
| 10:24 ET | 600 | 1.7599 |
| 10:27 ET | 4885 | 1.7599 |
| 10:38 ET | 1300 | 1.7691 |
| 10:40 ET | 1800 | 1.77 |
| 10:42 ET | 1771 | 1.7838 |
| 10:47 ET | 1000 | 1.7706 |
| 10:49 ET | 13025 | 1.76 |
| 10:56 ET | 5996 | 1.7799 |
| 11:03 ET | 3500 | 1.779 |
| 11:07 ET | 201 | 1.7624 |
| 11:09 ET | 200 | 1.775 |
| 11:16 ET | 1000 | 1.771 |
| 11:18 ET | 2300 | 1.7799 |
| 11:25 ET | 1974 | 1.7751 |
| 11:32 ET | 1500 | 1.77 |
| 11:36 ET | 1000 | 1.765 |
| 11:39 ET | 10300 | 1.76 |
| 11:43 ET | 678 | 1.75 |
| 11:48 ET | 1987 | 1.7501 |
| 11:54 ET | 500 | 1.75 |
| 11:56 ET | 3455 | 1.7592 |
| 11:59 ET | 12276 | 1.73 |
| 12:01 ET | 8200 | 1.735 |
| 12:03 ET | 951 | 1.72 |
| 12:08 ET | 600 | 1.72 |
| 12:10 ET | 4000 | 1.73 |
| 12:12 ET | 400 | 1.7338 |
| 12:15 ET | 350 | 1.73 |
| 12:17 ET | 3575 | 1.74 |
| 12:19 ET | 598 | 1.7307 |
| 12:21 ET | 7899 | 1.7308 |
| 12:24 ET | 250 | 1.7307 |
| 12:26 ET | 1500 | 1.74 |
| 12:28 ET | 1000 | 1.7301 |
| 12:30 ET | 300 | 1.73 |
| 12:32 ET | 1600 | 1.73 |
| 12:33 ET | 1000 | 1.73 |
| 12:42 ET | 489 | 1.72 |
| 12:44 ET | 4085 | 1.7211 |
| 12:46 ET | 518 | 1.72 |
| 12:48 ET | 8011 | 1.71 |
| 12:50 ET | 4300 | 1.715 |
| 12:55 ET | 100 | 1.715 |
| 12:57 ET | 100 | 1.715 |
| 01:00 ET | 1967 | 1.715 |
| 01:13 ET | 100 | 1.715 |
| 01:15 ET | 500 | 1.71 |
| 01:20 ET | 200 | 1.715 |
| 01:24 ET | 1000 | 1.716 |
| 01:27 ET | 300 | 1.715 |
| 01:29 ET | 583 | 1.7185 |
| 01:31 ET | 5600 | 1.71 |
| 01:33 ET | 790 | 1.71 |
| 01:42 ET | 6010 | 1.71 |
| 01:44 ET | 530 | 1.7094 |
| 01:45 ET | 300 | 1.7 |
| 01:47 ET | 300 | 1.7 |
| 01:56 ET | 100 | 1.705 |
| 02:02 ET | 852 | 1.7 |
| 02:03 ET | 2300 | 1.7 |
| 02:05 ET | 700 | 1.71 |
| 02:07 ET | 1000 | 1.71 |
| 02:18 ET | 3500 | 1.69 |
| 02:20 ET | 6400 | 1.695 |
| 02:23 ET | 300 | 1.69 |
| 02:25 ET | 500 | 1.6999 |
| 02:27 ET | 1200 | 1.695 |
| 02:30 ET | 1200 | 1.695 |
| 02:32 ET | 1100 | 1.695 |
| 02:34 ET | 30449 | 1.68 |
| 02:36 ET | 5781 | 1.685 |
| 02:38 ET | 8108 | 1.7 |
| 02:43 ET | 650 | 1.695 |
| 03:15 ET | 8100 | 1.715 |
| 03:19 ET | 2910 | 1.7178 |
| 03:21 ET | 100 | 1.715 |
| 03:37 ET | 5300 | 1.715 |
| 03:39 ET | 100 | 1.715 |
| 03:44 ET | 5300 | 1.715 |
| 03:46 ET | 200 | 1.715 |
| 03:48 ET | 1885 | 1.715 |
| 03:51 ET | 31500 | 1.7 |
| 03:53 ET | 25541 | 1.7001 |
| 03:55 ET | 300 | 1.695 |
| 03:57 ET | 571 | 1.7 |
| 04:00 ET | 15640 | 1.71 |
Nov 12, 2024
Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update, from 9:03AM ET on Tuesday Nov 12, 2024 by Dow Jones
9:03AM ET on Tuesday Nov 12, 2024 by Dow Jones*DJ Milestone Pharmaceuticals 3Q Loss $9.44M >MIST, from 9:03AM ET on Tuesday Nov 12, 2024 by Dow Jones
9:03AM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Milestone Pharmaceuticals Inc | 96.4M | -2.1x | --- |
Oramed Pharmaceuticals Inc | 94.1M | 4.5x | --- |
Monopar Therapeutics Inc | 96.2M | -9.1x | --- |
Annovis Bio Inc | 96.2M | -1.8x | --- |
Genenta Science SPA | 89.4M | -9.7x | --- |
Fibrobiologics Inc | 97.4M | -2.7x | --- |
Company Information
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.
Contact Information
- Headquarters
- 420-1111 boul. Dr.-Frederik-PhilipsMONTREAL, QC, Canada H4M 2X6
- Phone
- 514-336-0444
- Fax
- 514-336-0444
Executives
- Non-Executive Independent Chairman of the Board
- Robert Wills
- President, Chief Executive Officer
- Joseph Oliveto
- Chief Financial Officer, Executive Vice President of Corporate Development
- Amit Hasija
- Chief Operating Officer
- Jeffrey Nelson
- Chief Medical Officer
- David Bharucha
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $96.4M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 53.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.79 |
EPS | $-0.81 |
Book Value | $0.50 |
P/E Ratio | -2.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
